Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Richer

Concepts (459)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2025
218
6.160
Why?
Receptors, Androgen
14
2025
148
5.600
Why?
Breast Neoplasms
48
2026
2373
4.700
Why?
MicroRNAs
17
2018
689
3.540
Why?
Androgen Receptor Antagonists
8
2021
35
2.270
Why?
Cell Line, Tumor
41
2026
3537
2.130
Why?
Anoikis
7
2021
31
2.090
Why?
Gene Expression Regulation, Neoplastic
35
2025
1439
2.040
Why?
Receptors, Estrogen
15
2025
400
2.030
Why?
Phenylthiohydantoin
7
2025
44
1.850
Why?
Tryptophan
4
2024
175
1.830
Why?
Receptors, Progesterone
24
2016
243
1.790
Why?
Estrogen Receptor alpha
6
2022
151
1.720
Why?
Tryptophan Oxygenase
5
2024
33
1.570
Why?
Ovarian Neoplasms
6
2024
595
1.080
Why?
Progesterone
16
2014
209
0.950
Why?
Neoplasm Invasiveness
4
2024
505
0.930
Why?
Palmitates
1
2025
21
0.930
Why?
Benzamides
8
2026
224
0.920
Why?
Heme
1
2026
89
0.910
Why?
Progestins
6
2014
65
0.890
Why?
Tamoxifen
10
2016
191
0.890
Why?
Drug Resistance, Neoplasm
8
2025
881
0.870
Why?
Oxidative Phosphorylation
1
2025
209
0.850
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2024
48
0.850
Why?
Ribonuclease III
2
2016
44
0.790
Why?
Neoplastic Stem Cells
3
2017
409
0.780
Why?
Epithelial Cells
3
2022
1112
0.770
Why?
Wound Healing
1
2026
355
0.770
Why?
DEAD-box RNA Helicases
2
2016
89
0.760
Why?
Epithelial-Mesenchymal Transition
5
2018
211
0.760
Why?
Adipokines
2
2024
57
0.740
Why?
Biomarkers, Tumor
7
2021
1321
0.730
Why?
Cell Proliferation
14
2021
2499
0.720
Why?
Tumor Microenvironment
7
2026
737
0.720
Why?
Kallikreins
1
2021
26
0.700
Why?
Nitriles
7
2025
205
0.690
Why?
Gene Expression Profiling
11
2018
1769
0.680
Why?
Female
67
2026
78763
0.670
Why?
Prostate-Specific Antigen
1
2021
162
0.660
Why?
Mice
26
2026
18338
0.640
Why?
RNA, Long Noncoding
2
2022
172
0.640
Why?
Membrane Transport Proteins
1
2021
153
0.640
Why?
Immunohistochemistry
8
2017
1710
0.640
Why?
Endometrial Neoplasms
6
2011
205
0.630
Why?
Neoplasm Recurrence, Local
6
2023
1150
0.620
Why?
Pulmonary Alveoli
1
2022
383
0.610
Why?
Trophoblasts
1
2022
218
0.610
Why?
Humans
95
2026
145491
0.610
Why?
Transcription Factors
13
2023
1733
0.610
Why?
Transforming Growth Factor beta1
1
2021
176
0.610
Why?
Cell Movement
9
2020
961
0.610
Why?
Androgen Antagonists
3
2017
92
0.610
Why?
Animals
41
2026
38141
0.600
Why?
Mammary Glands, Animal
4
2022
128
0.600
Why?
Repressor Proteins
6
2018
430
0.580
Why?
Homeodomain Proteins
5
2014
525
0.580
Why?
Alternative Splicing
2
2018
247
0.570
Why?
Macrophages
2
2026
1509
0.570
Why?
Cell Cycle
4
2021
595
0.570
Why?
Lung Neoplasms
2
2026
2664
0.560
Why?
Up-Regulation
7
2020
848
0.550
Why?
RNA Splicing Factors
1
2018
66
0.550
Why?
Mammary Neoplasms, Experimental
3
2017
62
0.540
Why?
Carcinoma, Endometrioid
2
2008
49
0.500
Why?
Xenograft Model Antitumor Assays
8
2021
929
0.490
Why?
Gonadal Steroid Hormones
1
2018
143
0.490
Why?
Lactation
2
2022
193
0.490
Why?
Lipogenesis
1
2016
62
0.480
Why?
MCF-7 Cells
4
2025
132
0.470
Why?
Antibody Specificity
1
2016
178
0.470
Why?
Paclitaxel
3
2017
256
0.470
Why?
Signal Transduction
19
2025
5202
0.460
Why?
Antineoplastic Agents
6
2018
2207
0.450
Why?
Receptor, trkB
2
2012
39
0.450
Why?
Receptors, Aryl Hydrocarbon
1
2015
60
0.440
Why?
Apoptosis
11
2020
2411
0.440
Why?
Fatty Acid Synthase, Type I
1
2014
11
0.430
Why?
Kynurenine
4
2024
103
0.420
Why?
RNA Interference
3
2015
473
0.410
Why?
Antibodies
1
2016
398
0.410
Why?
Receptors, Steroid
2
2010
41
0.400
Why?
Metformin
2
2014
324
0.400
Why?
TOR Serine-Threonine Kinases
1
2017
452
0.400
Why?
Gene Expression Regulation
8
2016
2594
0.380
Why?
Carnitine O-Palmitoyltransferase
2
2025
49
0.380
Why?
Chromatin
1
2016
555
0.360
Why?
CD8-Positive T-Lymphocytes
1
2018
917
0.360
Why?
Mutation
8
2025
4093
0.350
Why?
Sodium-Potassium-Exchanging ATPase
1
2012
54
0.350
Why?
Kruppel-Like Transcription Factors
1
2012
79
0.350
Why?
Neoplasm Metastasis
4
2026
691
0.340
Why?
Neoadjuvant Therapy
2
2020
466
0.340
Why?
Cystadenocarcinoma, Serous
2
2024
90
0.340
Why?
Antineoplastic Agents, Hormonal
5
2020
192
0.340
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1965
0.340
Why?
Disease Progression
6
2018
2862
0.330
Why?
Endometrium
2
2008
59
0.330
Why?
NF-kappa B
3
2025
660
0.330
Why?
Transcriptional Activation
5
2017
372
0.320
Why?
Mice, SCID
4
2020
369
0.320
Why?
Cell Transformation, Neoplastic
1
2012
337
0.300
Why?
Tubulin Modulators
1
2009
11
0.300
Why?
Cells
1
2009
25
0.290
Why?
Estradiol
6
2016
507
0.290
Why?
3' Untranslated Regions
4
2014
150
0.290
Why?
Zinc Finger E-box-Binding Homeobox 1
4
2011
21
0.290
Why?
Uterine Neoplasms
2
2008
96
0.290
Why?
Cadherins
4
2012
200
0.280
Why?
Killer Cells, Natural
2
2025
480
0.280
Why?
Dirofilaria immitis
3
2010
3
0.270
Why?
Mice, Nude
5
2017
678
0.270
Why?
Neoplasms
5
2022
2897
0.270
Why?
Feedback, Physiological
2
2021
81
0.260
Why?
Trastuzumab
2
2017
117
0.250
Why?
Cell Nucleus
5
2017
593
0.250
Why?
Transfection
5
2012
925
0.250
Why?
Microtubules
1
2009
287
0.240
Why?
Epidermal Growth Factor
4
2005
161
0.240
Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2026
15
0.240
Why?
Phosphodiesterase 4 Inhibitors
1
2026
12
0.240
Why?
Genetic Diseases, Inborn
2
2017
45
0.240
Why?
Cyclopropanes
1
2026
84
0.230
Why?
Bilirubin
1
2026
99
0.230
Why?
Heme Oxygenase-1
1
2026
74
0.230
Why?
Cyclic AMP Response Element-Binding Protein
1
2026
145
0.220
Why?
Aminopyridines
1
2026
129
0.220
Why?
Fibrillin-1
1
2024
6
0.220
Why?
Alveolar Epithelial Cells
1
2026
120
0.220
Why?
Anilides
2
2016
84
0.220
Why?
Chemokine CCL2
1
2025
112
0.220
Why?
Mice, Inbred NOD
3
2020
613
0.220
Why?
Marfan Syndrome
1
2024
46
0.210
Why?
Down-Regulation
6
2016
616
0.210
Why?
Gene Expression
4
2020
1478
0.210
Why?
Cell Differentiation
1
2012
2045
0.210
Why?
Microarray Analysis
2
2016
116
0.210
Why?
Pharmacology, Clinical
1
2023
9
0.200
Why?
Molecular Targeted Therapy
2
2018
439
0.200
Why?
Oligonucleotide Array Sequence Analysis
5
2010
751
0.200
Why?
Tumor Cells, Cultured
11
2020
883
0.180
Why?
Milk Proteins
2
1999
33
0.180
Why?
Mammary Glands, Human
2
2014
68
0.180
Why?
Genetic Variation
2
2024
988
0.180
Why?
Epigenesis, Genetic
2
2018
672
0.170
Why?
NF-E2-Related Factor 2
1
2022
100
0.170
Why?
Epithelium
1
2022
310
0.170
Why?
Estrogens
3
2020
364
0.170
Why?
Neoplastic Cells, Circulating
1
2022
81
0.170
Why?
Mice, Transgenic
2
2017
2189
0.170
Why?
Promoter Regions, Genetic
6
2014
1247
0.170
Why?
Neoplasms, Second Primary
1
2022
102
0.160
Why?
Neoplasm Proteins
2
2018
441
0.160
Why?
DNA-Binding Proteins
6
2018
1487
0.160
Why?
Semaphorins
1
2020
37
0.160
Why?
Epoxy Compounds
1
2020
31
0.160
Why?
Androgens
1
2021
178
0.160
Why?
Gene Knockdown Techniques
2
2020
335
0.150
Why?
Cytoreduction Surgical Procedures
1
2020
70
0.150
Why?
Immune Tolerance
1
2022
384
0.150
Why?
Respiratory Mucosa
1
2022
322
0.150
Why?
Transcription, Genetic
9
2012
1468
0.150
Why?
STAT5 Transcription Factor
3
2014
50
0.150
Why?
RNA, Messenger
7
2011
2820
0.140
Why?
Chemotherapy, Adjuvant
1
2020
427
0.140
Why?
Mitochondria
1
2025
990
0.140
Why?
Pregnancy
3
2022
7197
0.140
Why?
Prolactin
1
1998
87
0.140
Why?
RNA, Small Interfering
3
2020
632
0.140
Why?
Gene Amplification
1
2018
120
0.140
Why?
Biomedical Research
1
2025
718
0.140
Why?
Immunoblotting
3
2010
294
0.130
Why?
Endometrial Hyperplasia
2
2008
6
0.130
Why?
Binding Sites
5
2016
1313
0.130
Why?
Antigens, CD
1
2020
557
0.130
Why?
Lymphocytes, Tumor-Infiltrating
1
2018
153
0.130
Why?
Mammary Tumor Virus, Mouse
1
2017
42
0.130
Why?
Cluster Analysis
4
2008
517
0.130
Why?
Dihydrotestosterone
1
2017
40
0.130
Why?
Histone Acetyltransferases
3
2006
57
0.120
Why?
Immunity, Cellular
1
2018
273
0.120
Why?
Neoplasm Transplantation
2
2014
246
0.120
Why?
Estrogen Receptor Modulators
3
2008
14
0.120
Why?
Heterografts
1
2017
143
0.120
Why?
Everolimus
1
2017
113
0.120
Why?
Fatty Acids
1
2020
459
0.120
Why?
Cyclohexanes
1
2016
23
0.120
Why?
Tumor Suppressor Proteins
2
2014
320
0.120
Why?
Enzyme Inhibitors
3
2024
821
0.120
Why?
Trans-Activators
4
2006
397
0.120
Why?
Carcinogenesis
1
2018
227
0.120
Why?
Hyaluronan Receptors
2
2014
105
0.110
Why?
Ovary
1
2017
227
0.110
Why?
Placenta
1
2022
784
0.110
Why?
Transplantation, Heterologous
2
2014
169
0.110
Why?
Genes
1
2015
226
0.110
Why?
Genetic Association Studies
1
2017
369
0.110
Why?
Phosphoproteins
2
2008
339
0.110
Why?
Hormones
1
2015
133
0.110
Why?
Sequence Analysis, DNA
2
2015
831
0.110
Why?
Exome
1
2015
227
0.100
Why?
Tosyl Compounds
1
2014
17
0.100
Why?
Drug Delivery Systems
1
2017
382
0.100
Why?
Genes, Reporter
2
2012
276
0.100
Why?
Ligands
6
2023
667
0.100
Why?
Protein Transport
1
2015
438
0.100
Why?
Sarcoma, Ewing
1
2015
103
0.100
Why?
HEK293 Cells
1
2016
743
0.100
Why?
PTEN Phosphohydrolase
1
2015
164
0.100
Why?
In Situ Hybridization
2
2010
318
0.100
Why?
Genetic Predisposition to Disease
2
2024
2355
0.100
Why?
Cells, Cultured
2
2016
4127
0.100
Why?
Cellular Reprogramming
1
2014
99
0.100
Why?
Cysteine Proteinase Inhibitors
1
1993
49
0.100
Why?
Neurotrophin 3
1
2012
10
0.100
Why?
Cell Adhesion
2
2012
452
0.100
Why?
Disease Models, Animal
2
2021
4559
0.090
Why?
Autocrine Communication
1
2012
38
0.090
Why?
Phosphatidylinositol 3-Kinases
1
2015
380
0.090
Why?
Ketones
1
1993
53
0.090
Why?
Clinical Trials as Topic
1
2018
1058
0.090
Why?
Metalloendopeptidases
1
1992
63
0.090
Why?
Cysteine Endopeptidases
1
1992
74
0.090
Why?
Aromatase Inhibitors
2
2014
74
0.090
Why?
Transduction, Genetic
1
2012
132
0.090
Why?
Family
1
2017
687
0.090
Why?
Middle Aged
7
2024
36176
0.090
Why?
Disease-Free Survival
1
2014
771
0.090
Why?
Nuclear Proteins
5
2000
743
0.090
Why?
Gene Silencing
2
2014
202
0.090
Why?
Luciferases
1
2012
152
0.090
Why?
Carrier Proteins
2
2023
733
0.090
Why?
Zinc Finger E-box Binding Homeobox 2
1
2011
6
0.090
Why?
Tubulin
1
2012
146
0.080
Why?
Receptors, Leptin
1
2011
25
0.080
Why?
Tissue Array Analysis
2
2008
49
0.080
Why?
Tumor Burden
1
2012
324
0.080
Why?
Mice, Inbred C57BL
2
2016
5989
0.080
Why?
GTPase-Activating Proteins
1
2011
81
0.080
Why?
Predictive Value of Tests
1
2016
2129
0.080
Why?
Fibronectins
1
2011
132
0.080
Why?
Protein Biosynthesis
2
2012
455
0.080
Why?
Microfilament Proteins
1
2011
136
0.080
Why?
Cell Transdifferentiation
1
2010
31
0.080
Why?
HeLa Cells
5
2006
633
0.080
Why?
Retinoid X Receptors
1
2010
38
0.080
Why?
Cyclins
3
1999
79
0.080
Why?
Real-Time Polymerase Chain Reaction
1
2010
339
0.080
Why?
DNA, Complementary
4
2008
273
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2010
975
0.080
Why?
Breast
2
2022
157
0.080
Why?
Protein Isoforms
4
2006
396
0.080
Why?
Lung
1
2022
4103
0.070
Why?
Cell Line, Transformed
1
2009
138
0.070
Why?
Prognosis
3
2024
4323
0.070
Why?
Inflammation
1
2020
2883
0.070
Why?
Receptors, Cytoplasmic and Nuclear
2
2023
207
0.070
Why?
Perilipin-1
1
2008
16
0.070
Why?
S100 Proteins
1
2008
35
0.070
Why?
Glucose
1
2013
1039
0.070
Why?
Reproducibility of Results
1
2016
3424
0.070
Why?
Leiomyoma
1
2008
59
0.070
Why?
Drug Interactions
1
2009
404
0.070
Why?
Aged
5
2024
26125
0.060
Why?
Glycoproteins
2
2024
353
0.060
Why?
Hysterectomy
1
2008
137
0.060
Why?
Interleukin-6
2
2024
772
0.060
Why?
Receptor, IGF Type 1
1
2006
63
0.060
Why?
Molecular Sequence Data
6
2010
2910
0.060
Why?
Stem Cells
1
2010
626
0.060
Why?
Survival Rate
2
2020
2093
0.060
Why?
Argentina
1
2025
30
0.050
Why?
Canada
2
2017
434
0.050
Why?
Precancerous Conditions
1
2006
166
0.050
Why?
Thromboplastin
1
2004
64
0.050
Why?
Cyclin-Dependent Kinase Inhibitor p21
3
1999
106
0.050
Why?
B7-1 Antigen
1
2024
55
0.050
Why?
Neoplasm Staging
1
2008
1468
0.050
Why?
Hypoglycemic Agents
1
2013
1392
0.050
Why?
Protein Binding
4
2010
2250
0.050
Why?
Obesity
1
2017
3076
0.050
Why?
Neoplasm Grading
1
2024
311
0.050
Why?
Ovariectomy
2
2017
164
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2006
456
0.050
Why?
Amino Acid Sequence
4
2010
2137
0.050
Why?
Congresses as Topic
1
2025
223
0.050
Why?
Postmenopause
3
2017
391
0.050
Why?
Core Binding Factor Alpha 2 Subunit
1
2023
30
0.050
Why?
Genome, Human
1
2024
420
0.050
Why?
ErbB Receptors
1
2005
635
0.050
Why?
Immune Evasion
1
2022
62
0.040
Why?
Biology
1
2022
89
0.040
Why?
Larva
2
1993
245
0.040
Why?
Promegestone
4
2005
9
0.040
Why?
B7-H1 Antigen
1
2024
243
0.040
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1999
165
0.040
Why?
Mifepristone
2
2000
53
0.040
Why?
Vascular Endothelial Growth Factor A
1
2004
550
0.040
Why?
Drug Resistance
2
2000
146
0.040
Why?
Leukocytes, Mononuclear
1
2024
573
0.040
Why?
Fibroblasts
1
2006
1023
0.040
Why?
Adult
4
2016
40707
0.040
Why?
Zinc
1
2024
297
0.040
Why?
Mammals
1
2022
296
0.040
Why?
GPI-Linked Proteins
1
2020
81
0.040
Why?
Antigens, Nuclear
1
2000
15
0.040
Why?
Exons
2
1999
363
0.040
Why?
Treatment Outcome
1
2015
11831
0.040
Why?
Poly(ADP-ribose) Polymerases
1
2000
85
0.040
Why?
Chromosomes, Human, Pair 17
1
1999
54
0.040
Why?
Postpartum Period
1
2022
373
0.040
Why?
Genomics
1
2024
834
0.040
Why?
Adenocarcinoma
1
2006
923
0.040
Why?
Young Adult
1
2016
14192
0.040
Why?
Receptor Cross-Talk
1
1998
21
0.040
Why?
Immunological Synapses
1
2018
16
0.040
Why?
p300-CBP Transcription Factors
1
2018
25
0.040
Why?
DNA Helicases
1
2000
141
0.040
Why?
STAT1 Transcription Factor
1
1998
66
0.040
Why?
Intercellular Adhesion Molecule-1
1
2018
130
0.030
Why?
Aged, 80 and over
2
2008
8326
0.030
Why?
Proto-Oncogene Proteins c-fos
1
1998
196
0.030
Why?
Drug Synergism
1
1998
353
0.030
Why?
Oxygenases
1
1997
12
0.030
Why?
Receptor, ErbB-3
1
2017
48
0.030
Why?
Biological Transport
1
1998
422
0.030
Why?
Combined Modality Therapy
1
2020
1269
0.030
Why?
Mitogen-Activated Protein Kinases
1
1998
287
0.030
Why?
Cell Culture Techniques
1
2020
373
0.030
Why?
Consanguinity
1
2017
49
0.030
Why?
Male
3
2021
72817
0.030
Why?
Analysis of Variance
2
2005
1304
0.030
Why?
STAT3 Transcription Factor
1
1998
205
0.030
Why?
Carcinogens
1
1997
123
0.030
Why?
Ribosomal Proteins
1
1997
94
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2017
268
0.030
Why?
Steroids
1
2017
160
0.030
Why?
Muscle, Smooth, Vascular
1
1999
444
0.030
Why?
Sequence Alignment
2
2010
371
0.030
Why?
Siblings
1
2017
195
0.030
Why?
Oxidation-Reduction
1
2020
1080
0.030
Why?
Saccharomyces cerevisiae Proteins
1
2000
419
0.030
Why?
Pedigree
1
2017
515
0.030
Why?
Chromatography, Liquid
1
2017
445
0.030
Why?
Nuclear Receptor Co-Repressor 1
3
2000
11
0.030
Why?
Histones
2
2014
663
0.030
Why?
Proto-Oncogene Protein c-fli-1
1
2015
30
0.030
Why?
Mice, Inbred BALB C
1
2017
1261
0.030
Why?
Base Sequence
3
2008
2180
0.030
Why?
Keratin-5
1
2014
44
0.030
Why?
Nuclear Receptor Coactivator 1
2
2006
5
0.030
Why?
Mass Spectrometry
1
2017
744
0.030
Why?
Genetic Testing
1
2017
480
0.030
Why?
Testosterone
1
2017
413
0.020
Why?
DNA Primers
2
2008
507
0.020
Why?
Dipeptides
1
1993
56
0.020
Why?
Adipose Tissue
1
2017
644
0.020
Why?
Chromatography
1
1992
27
0.020
Why?
Microscopy, Electron
1
1993
413
0.020
Why?
Elastin
1
1992
78
0.020
Why?
Hydrolysis
1
1992
199
0.020
Why?
Protease Inhibitors
1
1992
101
0.020
Why?
High-Throughput Nucleotide Sequencing
1
2015
553
0.020
Why?
Genotype
1
2017
1853
0.020
Why?
Follow-Up Studies
1
2020
5426
0.020
Why?
Blotting, Northern
1
2010
203
0.020
Why?
Oligopeptides
1
1992
266
0.020
Why?
Cell Size
1
2010
92
0.020
Why?
COS Cells
2
2003
177
0.020
Why?
Cell Dedifferentiation
1
2010
32
0.020
Why?
DNA, Helminth
1
2010
26
0.020
Why?
Collagen
1
1992
453
0.020
Why?
NIH 3T3 Cells
1
2010
147
0.020
Why?
Electrophoretic Mobility Shift Assay
1
2010
88
0.020
Why?
Nuclear Receptor Co-Repressor 2
2
2000
11
0.020
Why?
DNA Methylation
1
2014
667
0.020
Why?
Matrix Metalloproteinase 11
1
2008
4
0.020
Why?
Phosphorylation
2
2005
1707
0.020
Why?
Rats
1
2017
5581
0.020
Why?
Phenotype
1
2017
3157
0.020
Why?
RNA, Neoplasm
1
2008
83
0.020
Why?
Cell Division
2
2000
753
0.020
Why?
Dose-Response Relationship, Drug
2
2005
2030
0.020
Why?
Myometrium
1
2008
38
0.020
Why?
Extracellular Matrix
1
1992
562
0.020
Why?
Androstadienes
1
2008
75
0.020
Why?
DNA, Neoplasm
1
2008
158
0.020
Why?
Trypan Blue
1
2006
5
0.020
Why?
Comet Assay
1
2006
14
0.020
Why?
United States
1
2025
16115
0.020
Why?
Nuclear Receptor Coactivator 3
1
2006
5
0.020
Why?
Insulin Receptor Substrate Proteins
1
2006
55
0.020
Why?
Membrane Potential, Mitochondrial
1
2006
74
0.020
Why?
Radiation, Ionizing
1
2006
86
0.010
Why?
Staining and Labeling
1
2006
153
0.010
Why?
Mutant Proteins
1
2006
104
0.010
Why?
Recombinant Fusion Proteins
2
2000
667
0.010
Why?
Biomarkers
1
2017
4283
0.010
Why?
Amino Acid Motifs
1
2006
220
0.010
Why?
Caspase 3
1
2006
234
0.010
Why?
Androstenes
1
2005
16
0.010
Why?
Proteasome Endopeptidase Complex
1
2006
153
0.010
Why?
Medroxyprogesterone Acetate
1
2005
33
0.010
Why?
Levonorgestrel
1
2005
34
0.010
Why?
Desogestrel
1
2005
45
0.010
Why?
Protein Structure, Secondary
1
2006
366
0.010
Why?
Neuroblastoma
1
2006
174
0.010
Why?
Alkaline Phosphatase
1
2005
144
0.010
Why?
Insulin-Like Growth Factor I
1
2006
317
0.010
Why?
Sucrose
1
2004
115
0.010
Why?
DNA Repair
1
2006
256
0.010
Why?
Adenosine Triphosphate
1
2006
503
0.010
Why?
Protein Structure, Tertiary
1
2006
850
0.010
Why?
Microscopy, Confocal
1
2004
318
0.010
Why?
DNA Damage
1
2006
434
0.010
Why?
Reactive Oxygen Species
1
2006
602
0.010
Why?
Sequence Homology, Amino Acid
1
2003
393
0.010
Why?
Progesterone Congeners
1
2002
8
0.010
Why?
Mutagenesis
1
2003
194
0.010
Why?
Uterus
1
2003
225
0.010
Why?
Dimerization
1
2002
190
0.010
Why?
Child, Preschool
1
2017
11837
0.010
Why?
Cell Survival
1
2004
1094
0.010
Why?
Plasmids
1
2002
375
0.010
Why?
Ku Autoantigen
1
2000
11
0.010
Why?
DNA-Activated Protein Kinase
1
2000
14
0.010
Why?
Glutathione Transferase
1
2000
96
0.010
Why?
Recombinant Proteins
1
2003
1367
0.010
Why?
Culture Techniques
1
1999
66
0.010
Why?
Methionine
1
2000
162
0.010
Why?
Peptide Fragments
1
2003
693
0.010
Why?
Growth Substances
1
1999
138
0.010
Why?
Antibodies, Monoclonal
1
2006
1511
0.010
Why?
Estrogen Receptor beta
1
1999
40
0.010
Why?
Cricetinae
1
1999
299
0.010
Why?
Phosphotyrosine
1
1998
38
0.010
Why?
Receptors, Growth Factor
1
1998
53
0.010
Why?
RNA
1
2005
929
0.010
Why?
Premenopause
1
1999
123
0.010
Why?
Retrospective Studies
1
2017
17269
0.010
Why?
JNK Mitogen-Activated Protein Kinases
1
1998
153
0.010
Why?
Sp1 Transcription Factor
1
1998
24
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
1998
135
0.010
Why?
Chromosome Mapping
1
1999
509
0.010
Why?
Estrogen Antagonists
1
1998
37
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
1998
171
0.010
Why?
Isomerism
1
1997
57
0.010
Why?
Gene Deletion
1
1999
392
0.010
Why?
p38 Mitogen-Activated Protein Kinases
1
1998
265
0.010
Why?
Leucine Zippers
1
1997
13
0.010
Why?
Yeasts
1
1997
51
0.010
Why?
Autoantigens
1
2000
426
0.010
Why?
Blotting, Western
1
1998
1162
0.010
Why?
Child
1
2015
22680
0.010
Why?
Polymerase Chain Reaction
1
1998
1049
0.010
Why?
Time Factors
1
2004
7171
0.010
Why?
Cell Line
1
1998
2823
0.010
Why?
Cytokines
1
1999
2054
0.010
Why?
Models, Biological
1
1998
1815
0.010
Why?
Richer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)